C20H28N6O4
Neat
416.48
Room Temperature
666816-91-7; (R)-tert-butyl 1-(7-(but-2-ynyl)-3-methyl-2, 6-dioxo-2, 3, 6, 7-tetrahydro-1H-purin-8-yl)piperidin-3-ylcarbamate; 3-Methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tertbutyloxycarbonylamino)piperidin-1-yl]-xanthine; tert-butyl N-[(3R)-1-(7-but-2-ynyl-3-methyl-2, 6-dioxopurin-8-yl)piperidin-3-yl]carbamate; Linagliptin impurity 14; MKEXJLGKOKCUEB-CYBMUJFWSA-N; Linagliptin Impurity L; SCHEMBL638558; 2Z5B2A3387; F19282; 3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-tert-butoxycarbonylaminopiperidin-1-yl)xanthine; (R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2, 6-dioxo-2, 3, 6, 7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate; (R)-tert-butyl1-(7-(but-2-ynyl)-3-methyl-2, 6-dioxo-2, 3, 6, 7-tetrahydro-1H-purin-8-yl)piperidin-3-ylcarbamate; 3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert.-butyloxycarbonyl-amino)-piperidin-1-yl]-xanthine; 3-Methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tertbutyloxycarbonylamino)piperidin-1-yl]-xanthine; Carbamic acid, [(3R)-1-[7-(2-butynyl)-2, 3, 6, 7-tetrahydro-3-methyl-2, 6-dioxo-1H-purin-8-yl]-3-piperidinyl]-, 1, 1-dimethylethyl ester (9CI); Carbamic acid, [(3R)-1-[7-(2-butynyl)-2, 3, 6, 7-tetrahydro-3-methyl-2, 6-dioxo-1H-purin-8-yl]-3-piperidinyl]-, 1, 1-dimethylethyl ester; tert-Butyl 1-(7-(but-2-ynyl)-3-methyl-2, 6-dioxo-2, 3, 6, 7-tetrahydro-1H-purin-8-yl)piperidin-3-ylcarbamate and (R)-
tert-butyl N-[(3R)-1-(7-but-2-ynyl-3-methyl-2 and 6-dioxopurin-8-yl)piperidin-3-yl]carbamate
InChI=1S/C20H28N6O4/c1-6-7-11-26-14-15(24(5)18(28)23-16(14)27)22-17(26)25-10-8-9-13(12-25)21-19(29)30-20(2,3)4/h13H,8-12H2,1-5H3,(H,21,29)(H,23,27,28)/t13-/m1/s1